Continued disruption is driving transformational change in industry supply chains. Companies are urgently evolving to new levels of technology and process maturity to address increasing challenges.

Crucially, an effective supply chain requires resilience. Resilience across every facet of the pharmaceutical supply chain is paramount, whether ecological, societal, organisational, or psychological.

This past week Joe Biden announced the creation of a “White House Council on Supply Chain Resilience” (CSCR or the Council). The National Security Advisor and National Economic Advisor will co ...

Cost management is the number one priority for today’s C-suites, and a recent survey of 770 CEOs, CFOs and COOs by BCG shows that supply chain disruption is one of the top two reasons for ...

In this White Paper, Professor Lenny Koh and colleagues explore how companies can address the dual imperative of resilience and transparency in modern supply chains to tackle sudden disruptions and ...

Supply chain disruptions are taking centre stage ... These disruptions serve as a clarion call for companies to infuse greater resilience and flexibility into their operations.